ICAN, Exon20Group, METCrusaders, Biomarker Collaborative, PD-L1 Amplfieds

Support ICAN, International Cancer Advocacy Network

RadDatePicker
RadDatePicker
Open the calendar popup.
 
The Exon 20 Group
Biomarker Collaborative
NRG1 Energizers
The MET Crusaders
PD-L1 Amplifieds
Named Programs
Notifications
Tax Receipt *(required)

 

Please enter a donation amount or you may select an amount by clicking a button.


To donate to a specific named program, please see the Named Patient Programs section.

Click "Select One" and  scroll through the list to select the program to which you would like to contribute. 


 

Donations to the Exon 20 Group support the following:

 
1) Direct Navigation of Exon 20 Insertion Cases, both EGFR Exon 20 Insertions and HER2 Exon 20 Insertions;

2) Patient-Reported Outcomes Surveys of our Exon 20 and Rare Cancers Communities;

3) Cutting-Edge Research at Top Laboratories Focusing on Exon 20 Resistance Mutations

4) Public Policy Initiatives to Accelerate the Rare Lung Cancer Treatment Pipeline

5) Health Information Technology Initiatives

6) National, Global, and Country-by Country Sequencing and Profiling Campaigns to Identify Exon 20 Insertions and Point Mutations on Diagnosis
 

Named Programs 

*For more information about ICAN's Named Patient Cancer Programs, click here.


The tax receipt you receive from ICAN via email simultaneously  with your online donation is your official donor gift receipt. Please retain it for your records.